Ubs Group Ag Morpho Sys Ag Transaction History
Ubs Group Ag
- $400 Billion
- Q2 2024
A detailed history of Ubs Group Ag transactions in Morpho Sys Ag stock. As of the latest transaction made, Ubs Group Ag holds 35,900 shares of MOR stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,900
Previous 35,900
-0.0%
Holding current value
$0
Previous $651,000
0.31%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding MOR
# of Institutions
43Shares Held
1.84MCall Options Held
79.8KPut Options Held
688K-
Black Rock Inc. New York, NY1.02MShares$00.0% of portfolio
-
Segantii Capital Management LTD463KShares$01.04% of portfolio
-
Tekla Capital Management LLC177KShares$00.05% of portfolio
-
Hennion & Walsh Asset Management, Inc.125KShares$00.12% of portfolio
-
Engineers Gate Manager LP New York, NY13.4KShares$00.01% of portfolio
About MorphoSys AG
- Ticker MOR
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 136,614,000
- Description
- MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...